MelanocortinOut of Stock Melanotan 2 (MT2) 10mg Melanotan II (MT-II) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), developed at the University of Arizona as part of melanocortin receptor research
This powerful combination accelerates the healing of muscles, tendons, ligaments, and bones, making it ideal for injury recovery, post-surgical rehabilitation, and improving joint health
"Growth hormone secretagogues: Their role and clinical applications." Endocrine Reviews, 30(5), 545575
The expected dose for the standard 50/10/10 milligram GLOW blend lands in the range of 250 to 600 micrograms of BPC-157 daily, with proportional GHK-Cu and TB-500
Transition planning between vial sizes Most researchers use 10mg vials for phases 1-2 (1-2mg weekly, consuming about 4-8mg per 4-week block), then switch to 20mg or 30mg vials for phases 3-5 when weekly consumption increases significantly